Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10485479 | 0.84 | FFAR4 (0.31) | FFAR4 | |
| SCHEMBL8668032 | 0.79 | MEN1 (0.33) | MEN1KMT2AFFAR4 | |
| SCHEMBL10785290 | 0.78 | MAOA (0.38) | — | |
| SCHEMBL8817061 | 0.74 | HTR2A (0.34) | MEN1KMT2AFFAR4 | |
| SCHEMBL7024322 | 0.73 | DRD2 (0.33) | MEN1KMT2A | |
| SCHEMBL6052739 | 0.72 | KEAP1 (0.35) | — | |
| SCHEMBL10558051 | 0.70 | KDM4E (0.36) | — | |
| SCHEMBL10556130 | 0.69 | ACKR3 (0.30) | — | |
| Hydrochloric Acid SCHEMBL4469284 | 0.69 | KCNH2 (0.35) | MEN1KMT2A | |
| SCHEMBL4909217 | 0.69 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1767536-B1 | QUINOLONECARBOXYLIC ACID COMPOUNDS, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF | INST MED BIOTECHNOLOGY CAMS (CN) | 2011-06-29 | — | — | EP | disclosed |
| US-7759362-B2 | Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof | INSTITUT OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2010-07-20 | — | — | US | disclosed |
| US-20070219231-A1 | Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof | XINCHANG PHARMACEUTICAL FACTORY, ZHEJIANG MEDICINE CO. LTD. (CN) | 2007-09-20 | — | — | US | disclosed |
| EP-1767536-A1 | QUINOLONE CARBOXYLIC ACID DERIVATIVES, THEREOF PREPARATION AND USAGE | Institute of Medicinal Biotechnology, Chinese Acadamy of Medical Sciences (CN) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219231-A1 | Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof | NQO2, ABCG2, DHX15 | MEN1 2734/4885KMT2A 3454/4885FFAR4 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.